Doctor profile · Federal record
Dr. Andrew Iliff, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Columbia, MO
- NPI 1851654818
- Accepts Medicare
- MIPS 91.7 / 100 · 2023
- 14 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1705 E Broadway Ste 100
Columbia, MO 65201
(573) 874-7800
fax (573) 443-3627
Credentials & registration
- NPI registered
- June 2012 — 14 yrs on file
- Profile last updated
- February 17, 2025
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Missouri #2017040908
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851654818. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
285,495
Distinct HCPCS
10
Medicare allowed
$3,492,174
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 41,670 | 60 | $3 | |
J0641 |
Injection, levoleucovorin, not otherwise specified, 0.5 mg | 40,950 | 18 | $1 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 27,750 | 27 | $1 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 20,910 | 29 | $1 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 20,776 | 183 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 19,200 | 47 | $54 | |
J9025 |
Injection, azacitidine, 1 mg | 18,800 | 15 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 15,020 | 17 | $30 | |
J0185 |
Injection, aprepitant, 1 mg | 14,040 | 50 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 12,720 | 83 | $23 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 3,643. This provider delivers 78× the peer median.Open Payments
Industry payments received
All-time total
$4,162
Transactions
190
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 16 | $344.45 | |
| Novartis Pharmaceuticals Corporation | 20 | $339.94 | |
| AstraZeneca Pharmaceuticals LP | 18 | $308.23 | |
| Celgene Corporation | 24 | $268.83 | |
| ABBVIE INC. | 12 | $245.47 | |
| Genentech USA, Inc. | 15 | $229.21 | |
| PFIZER INC. | 13 | $200.51 | |
| E.R. Squibb & Sons, L.L.C. | 20 | $192.09 | |
| Daiichi Sankyo Inc. | 7 | $167.97 | |
| Gilead Sciences, Inc. | 9 | $164.54 | |
| Incyte Corporation | 10 | $164.15 | |
| GENZYME CORPORATION | 9 | $153.23 | |
| Janssen Biotech, Inc. | 7 | $147.74 | |
| Exelixis Inc. | 5 | $109.48 | |
| Eisai Inc. | 5 | $106.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,226
Patients
392
Total drug cost
$122,959
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 213 | 58 | $10,204 |
| Oxycodone Hcl | Generic | 115 | 41 | $1,631 |
| Prednisone | Generic | 109 | 31 | $1,087 |
| Dexamethasone | Generic | 107 | 44 | $1,611 |
| Omeprazole | Generic | 87 | 19 | $1,449 |
| Acyclovir | Generic | 71 | 15 | $1,508 |
| Eliquis (Apixaban) | Brand | 71 | 15 | $57,641 |
| Hydroxyurea | Generic | 69 | 14 | $2,103 |
| Levothyroxine Sodium | Generic | 67 | 23 | $726 |
| Ondansetron Hcl | Generic | 60 | 34 | $1,103 |
Hospital affiliations
Frequently asked questions
What is Dr. Andrew Iliff's medical specialty?
Dr. Andrew Iliff practices Hematology & Oncology Physician in Columbia, MO.
Where does Dr. Andrew Iliff practice?
Dr. Andrew Iliff practices at 1705 E Broadway Ste 100, Columbia, MO 65201. Office phone: 5738747800.
What is Dr. Andrew Iliff's NPI?
Dr. Andrew Iliff's National Provider Identifier (NPI) is 1851654818, issued by NPPES.
Does Dr. Andrew Iliff accept Medicare assignment?
Yes. Dr. Andrew Iliff accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andrew Iliff commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, levoleucovorin, not otherwise specified, 0.5 mg (HCPCS J0641); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439). Source: CMS Medicare Physician & Other Practitioners file.